Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-22T19:55:18.146Z Has data issue: false hasContentIssue false
  • English
  • Français

The Treatment of Depressive States with Imipramine Hydrochloride (Tofranil)

Published online by Cambridge University Press:  08 February 2018

J. T. Leyberg  and
J. C. Denmark
J. T. Leyberg
Affiliation:
Townleys Psychiatric Unit, Bolton Group of Hospitals
J. C. Denmark
Affiliation:
Townleys Psychiatric Unit, Bolton Group of Hospitals
Get access Rights & Permissions [Opens in a new window]

Extract

Drug treatment of depressive states has hitherto been somewhat disappointing but recent reports by Kuhn (1957, 1958), Kielholz and Battegay (1958) from Switzerland, and Azimo and Vispo (1958) from Canada have claimed that imipramine hydrochloride (Tofranil) has “thymoleptic” qualities and is of specific therapeutic value in states of endogenous depression and allied affective disorders.

Type
Original Articles
Information
Journal of Mental Science , Volume 105 , Issue 441 , October 1959 , pp. 1123 - 1126
Copyright
Copyright © Royal College of Psychiatrists, 1959 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Azima, H., and Vispo, R. H., Amer. J. Psychiat., 1958, 115, 245.CrossRefGoogle Scholar
Kielholz, P., and Battegay, R., Schweiz. med. Wschr., 1958, 88, 763.Google Scholar
Kuhn, R., ibid., 1957, 87, 1135.Google Scholar
Idem , Amer. J. Psychiat., 1958, 115, 459.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.